Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer
Clinical trial NCT05193292 · UNKNOWN
Trial details
- NCT number
- NCT05193292
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-01-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.